Focused on our patient-centric principles, our cost-effective portfolio of diagnostic products results in expedited treatment, better patient outcomes, and robust cost savings for the healthcare delivery system. Our expansive portfolio includes non-invasive at-home breath testing kits for Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), and carbohydrate malabsorption disorders, as well as MyGi Health, a cloud-based healthcare platform that enables patients to manage and understand their symptoms for a range of conditions.
Operating out of our CLIA-certified laboratory, and as an FDA-registered, ISO 13485 certified medical device manufacturer, we pride ourselves on our partnerships with leading health systems, hospitals, and private practices worldwide.
